Kaposi's sarcoma (KS) is a low-grade vascular neoplasm mediated by the human herpesvirus-8. Only 1 clinical subtype, the endemic/African subtype, commonly affects the pediatric population. Although ...

Barriers and Facilitators of Implementing Automated Radiotherapy Planning: A Multisite Survey of Low- and Middle-Income Country Radiation Oncology Providers Highly active antiretroviral therapy has an ...

Please provide your email address to receive an email when new articles are posted on . The incidence of Kaposi’s sarcoma and related death in East Africa has not improved in the last 5 years. In a ...

Incidence of Cancers Among Children Living With HIV in Malawi After Widespread Availability of Antiretroviral Therapy: A Population-Based Study Patients were evaluated at skin biopsy services in ...

Kaposi sarcoma commonly affects people with weakened immune systems, such as those with stage 3 HIV, also known as AIDS. However, taking antiretroviral drugs can reduce the risk of developing the ...

Investigators also examined which type of immunosuppression was associated with a higher likelihood of Kaposi sarcoma. Findings presented at this month’s National Comprehensive Cancer Network (NCCN) ...

Researchers conducted a serial cross-sectional study of 318 participants with KS from two tertiary care academic centers in California from January 2010 to February 2022. Participants were categorized ...

A new study has uncovered a genetic cause that may explain why some people develop Kaposi sarcoma despite having no apparent immune deficiency. The rare cancer, which forms in the cells lining blood ...

Researchers have developed a model of Kaposi sarcoma that could expedite the development of new drugs to treat the disease, which is the most common cancer in people living with HIV. Researchers at ...

Researchers at UNC Lineberger Comprehensive Cancer Center, after decades of research efforts, have developed a mouse model of Kaposi sarcoma that could be key to the development of new drugs to treat ...